In this video interview, Krinx Kong, chief commercial officer, Cognivia, discusses how trial design and timelines could be impacted by a potential mandate for placebo use across all vaccine trials.

Donald Trump withdrew his nominee for Surgeon General, Dr. Janette Nesheiwat, on Wednesday following controversy over her ...

With a demand that vaccine boosters be tested against placebos, RFK Jr. puts an old antivaccine claim at the forefront of ...

When the Department of Health and Human Services (HHS) announced a new requirement for placebo testing on all new vaccines ...

The FDA's decision to appoint Vinay Prasad, MD, MPH, to head its Center for Biologics Evaluation and Research (CBER) raised ...

In recent interviews, Health and Human Services Secretary Robert F. Kennedy Jr. has minimized the risk COVID-19 poses to kids ...

A blanket requirement for placebo-controlled trials threatens research ethics and vaccine access, it’s being argued.

Yes, according to leading vaccine physician Paul Offit, who denounced the new placebo-controlled trial requirements for ...

Kennedy is a longtime vaccine skeptic and conspiracy theorist, and his appointment to the country’s top health care policy ...

Health and Human Services Secretary Robert F. Kennedy Jr. has misleadingly claimed that vaccines are not tested in ...

The health and human services secretary, Robert F. Kennedy Jr., is known for his criticism of advisory panels, most recently ...